Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
about
New drugs approved in 2010Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Examining the use of ceftaroline in the treatment of Streptococcus pneumoniae meningitis with reference to human cathelicidin LL-37.Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Ceftaroline in complicated skin and skin-structure infections.Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumoniaTreatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury.Advances in MRSA drug discovery: where are we and where do we need to be?Current medical management of diabetic foot infections.The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challenges.Ceftaroline fosamil: a new broad-spectrum cephalosporin.Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Inhibitors targeting on cell wall biosynthesis pathway of MRSA.Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy.The times they are a-changin': new antibacterials for skin and skin structure infections.Staphylococcus aureus and its Bearing on Ophthalmic Disease.Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetationsMethicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam.
P2860
Q34753085-F2B67961-7BE5-4381-9960-E1DC26356D38Q35117981-2269FC86-0862-4B64-9299-C778F92975A0Q35168868-E6EBE840-BBEB-4302-9849-CD6AE146D9A4Q35191527-DBA480A3-110C-460D-A962-69CD2BAE1618Q35619094-51A71D96-2121-4F92-8B5F-7F07414B2148Q35715381-A0B48A58-0B70-4184-A53E-C868CFF249B5Q35752997-9FA5B959-041B-4985-A080-6F95893F91A3Q36363239-63151FAD-9737-42A6-AFA8-18F60C9C7FE0Q37112508-5F16BBCF-5600-43AF-B056-AA1058BAB4AAQ37809059-0AFD6171-EEFA-4A8F-A720-541F0389B9EEQ37853071-0C0C6C7F-E85C-48BF-9A40-EE31D994EE90Q37863942-1917AD28-E819-4AA2-BBAD-BC1B622AE75BQ38010783-ACC067A3-9EF4-4877-AE21-8269455F7135Q38025132-0B83F063-B719-46AB-B56E-C0C3326D3A5DQ38035171-48EC75E2-FC41-4B30-9FFE-7C925E7CE890Q38066654-B442E4BE-7BC2-4D19-8110-EE9D7E16D3E2Q38084726-D10C00EB-8DDA-4859-8EE2-1F86E2947A51Q38117077-088392FE-C0FE-4FE9-B012-546EBFD2ACFFQ38232494-EB82DF5F-AD59-4D14-9770-B2E2BC6AF70CQ38438503-6D9D690E-4C08-4F41-A09B-C509FFCC8400Q38672537-39B9853A-C0C1-4A2E-83A8-0D4D1B1B8CC0Q41074267-5ECFF85E-F84F-4691-A2F4-FCA9822A4B3AQ42224430-A683F5B7-F827-4662-A71C-CA950ABDC584Q54709896-92D2B134-3546-47E4-A09B-D0A682E0610A
P2860
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
@en
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
@nl
type
label
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
@en
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
@nl
prefLabel
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
@en
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
@nl
P2860
P356
P1433
P1476
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
@en
P2093
Michael J Rybak
Molly E Steed
P2860
P304
P356
10.1592/PHCO.30.4.375
P407
P577
2010-04-01T00:00:00Z